logo BDSP

Base documentaire

  1. Assessing the costs and benefits of medical research : the diabetic retinopathy study.

    Article - En anglais

    Significant amounts of scarce resources are devoted to medical research, but there have been few attempts to assess whether the benefits to society of these investments exceed the costs.

    A method for undertaking such an assessment has been developed and applied retrospectively to the Diabetic Retinopathy Study, a major clinical trial funded by the National Eye Institute from 1972-1981.

    It was estimated that the trial, which cost 810.5 million, generated a net saving of $2816 million to society ($231 million when the costs of lost production are excluded) (1982 prices) and a gain to patients of 279,000 vision years.

    Mots-clés Pascal : Diabète, Rétinopathie, Oeil pathologie, Complication, Essai clinique, Recherche scientifique, Evaluation, Analyse coût efficacité, Economie santé, Endocrinopathie, Arbre décision, Méthodologie, Etats Unis, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Diabetes mellitus, Retinopathy, Eye disease, Complication, Clinical trial, Scientific research, Evaluation, Cost efficiency analysis, Health economy, Endocrinopathy, Decision tree, Methodology, United States, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 92-0355250

    Code Inist : 002B21E02B. Création : 199406.